Symbols

KIDS

Orthopediatrics·NASDAQ

--(--)

Signals Analysis

Bullish signal 4

Bearish signal 1

Consensus Rating "Strong Buy"

Ample Liquidity

High Gross Profit Margin

Revenue Beats Expectation

EPS Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About KIDS

Orthopediatrics Corp.

An orthopedic company focused exclusively on advancing the field of pediatric orthopedics

Industry

Healthcare Equipment and Supplies

Established Date

08/31/2006

Listing Date

10/12/2017

Exchange

NASDAQ Stock Exchange

Full-time Employees

602

Fiscal Year Ends

12-31

Website

www.orthopediatrics.com

Security Type

Common stock

Office address

2850 Frontier Drive, Warsaw, Indiana 46582

Business

Introduction

Orthopediatrics Corp., originally organized as an Indiana limited liability company on August 31, 2006, was transformed into a Delaware corporation on November 30, 2007. The Company is a medical device company dedicated to the design, development and marketing of anatomically suitable implants, instruments and specialized braces for children with orthopedic diseases. It also operates orthotics and prosthetics clinics and has expanded its product portfolio and geographic reach through multiple acquisitions.

Company Financials

EPS

KIDS has released its 2025 Q4 earnings. EPS was reported at -0.43, versus the expected -0.3, missing expectations. The chart below visualizes how KIDS has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

KIDS has released its 2025 Q4 earnings report, with revenue of 61.60M, reflecting a YoY change of 16.97%, and net profit of -10.10M, showing a YoY change of 37.13%. The Sankey diagram below clearly presents KIDS's revenue sources and cost distribution.